The vaccine is based on encapsulated Bifidobacteria, and the patent was obtained both in the USA and Europe.
Morishita Jintan news release, May 29, 2104
The vaccine is based on encapsulated Bifidobacteria, and the patent was obtained both in the USA and Europe.
Morishita Jintan news release, May 29, 2104